- Home
- OGI vs EPRX Comparison
OGI vs EPRX Comparison
Compare OGI & EPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OGI
- EPRX
- Stock Information
- Founded
- OGI 2013
- EPRX 2011
- Country
- OGI Canada
- EPRX Canada
- Employees
- OGI N/A
- EPRX N/A
- Industry
- OGI Biotechnology: Pharmaceutical Preparations
- EPRX
- Sector
- OGI Health Care
- EPRX
- Exchange
- OGI Nasdaq
- EPRX NYSE
- Market Cap
- OGI 135.1M
- EPRX 130.0M
- IPO Year
- OGI N/A
- EPRX N/A
- Fundamental
- Price
- OGI $1.04
- EPRX $3.28
- Analyst Decision
- OGI
- EPRX Strong Buy
- Analyst Count
- OGI 0
- EPRX 1
- Target Price
- OGI N/A
- EPRX $9.00
- AVG Volume (30 Days)
- OGI 650.5K
- EPRX 11.9K
- Earning Date
- OGI 05-13-2025
- EPRX 05-07-2025
- Dividend Yield
- OGI N/A
- EPRX N/A
- EPS Growth
- OGI N/A
- EPRX N/A
- EPS
- OGI N/A
- EPRX N/A
- Revenue
- OGI $115,451,336.00
- EPRX N/A
- Revenue This Year
- OGI $50.11
- EPRX N/A
- Revenue Next Year
- OGI $16.16
- EPRX N/A
- P/E Ratio
- OGI N/A
- EPRX N/A
- Revenue Growth
- OGI N/A
- EPRX N/A
- 52 Week Low
- OGI $0.96
- EPRX $2.20
- 52 Week High
- OGI $2.37
- EPRX $4.48
- Technical
- Relative Strength Index (RSI)
- OGI 40.39
- EPRX N/A
- Support Level
- OGI $0.96
- EPRX N/A
- Resistance Level
- OGI $1.16
- EPRX N/A
- Average True Range (ATR)
- OGI 0.06
- EPRX 0.00
- MACD
- OGI 0.01
- EPRX 0.00
- Stochastic Oscillator
- OGI 40.00
- EPRX 0.00
About OGI Organigram Holdings Inc.
Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.
About EPRX EUPRAXIA PHARMACEUTICALS INC
Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product EP-104 is used for the treatment of osteoarthritis and eosinophilic esophagitis symptoms. The company leverages its proprietary Diffusphere technology to optimize drug delivery for applications with significant unmet medical needs.